Ardena is a Contract Development and Manufacturing Organization (CDMO) operating across Belgium, Europe, and the US. The company handles the pharmaceutical pipeline from drug discovery through clinical development and commercial market entry, with over 750 professionals running seven GMP/GLP facilities. Its work spans nanomedicine, drug substance and product development, manufacturing, clinical logistics, bioanalytical services, solid state research, fill and finish, and CMC regulatory support.
Three integrated platforms cover Small Molecules, Large Molecules, and Nanomedicines, serving pharmaceutical, biopharma, biotech, and nanomedicine companies. The scale is real - multiple regulated facilities, end-to-end CDMO capabilities, and a geographic footprint that bridges European and US markets.
For cybersecurity professionals, the attack surface is substantial: GMP/GLP environments demand rigorous data integrity, clinical logistics involve sensitive patient and trial data, and CMC regulatory workflows carry compliance obligations that don't tolerate gaps. Ardena operates in a sector where the threat model includes supply chain compromise, intellectual property exfiltration, and regulatory enforcement actions - all with direct patient safety implications.
